RxDoctor Payments Data

Kimberly Bradley, APRN

Family · Benton, KYNPI 1104801166

Payments from drug & device makers

$1,404in general payments, 2019–2025

Across 72 payments — averaging $19.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$489
  • Lilly USA, LLC$252
  • Novo Nordisk$161
  • Boehringer Ingelheim$86
  • Pfizer$71
  • Otsuka America Pharmaceutical, Inc.$65
  • plus $280 from 11 others

What the payments were for

  • Food & beverage$1,404100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,404 in reported general payments places this provider in the 70th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$55,942
Medicare patients
240
Services billed
1,095

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide46$60,856
OzempicSemaglutide16$28,944
JanuviaSitagliptin Phosphate17$25,232
FarxigaDapagliflozin Propanediol19$22,680
MounjaroTirzepatide16$20,126
RybelsusSemaglutide16$19,900
JardianceEmpagliflozin22$17,859
Diclofenac Sodium42$12,935
EliquisApixaban13$12,756
Ventolin HfaAlbuterol Sulfate30$2,048
Atorvastatin Calcium231$1,826
Novolog FlexpenInsulin Aspart13$1,687
Omeprazole127$1,640
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$1,628
Pantoprazole Sodium117$1,609

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$252$80,98362 claims
Novo NordiskOzempic, Rybelsus$161$48,84432 claims
AstraZenecaFarxiga$13$22,68019 claims
Boehringer IngelheimJardiance$86$17,85922 claims
PfizerEliquis$71$12,75613 claims
AbbVieSynthroid$489$83130 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,374 family providers in Kentucky.

Other family in Benton

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →